Transcriptional switching model for the regulation of tumorigenesis and metastasis by the ha-ras oncogene - transcriptional changes in the ha-ras tumor-suppressor gene lysyl oxidase - PubMed (original) (raw)
Transcriptional switching model for the regulation of tumorigenesis and metastasis by the ha-ras oncogene - transcriptional changes in the ha-ras tumor-suppressor gene lysyl oxidase
Z Su et al. Int J Oncol. 1995 Dec.
Abstract
A model system is described that allows an analysis of the molecular and biochemical changes associated with expression and suppression of the oncogenic and metastatic phenotype of cloned rat embryo fibroblast (CREF) cells. Ha-ras-transformed CREF cells are morphologically transformed, anchorage-independent and both tumorigenic and metastatic in athymic nude mice and syngeneic Fischer rats. Co-expression of the Ha-ras oncogene and Krev-1 tumor suppressor gene in CREF cells results in suppression of in vitro transformation. In contrast, Ha-ras/Krev-1 transformed CREF cells retain, with greatly extended latency periods, both tumorigenic and metastatic capabilities in athymic nude mice. The present study investigates changes in the Ha-ms suppressor gene, rrg (lysyl oxidase), during expression and suppression of the oncogenic phenotype in CREF cells. Nontumorigenic CREF cells and CREF cells transformed by the Ha-ras and Krev-1 gene that express a suppression in in vitro transformation contain elevated levels of lysyl oxidase mRNA and protein. In contrast, Ha-ms and Ha-ras/Krev-1 nude mouse tumor- and nude mouse lung metastasis-derived CREF cells contain reduced levels of lysyl oxidase mRNA and protein. Nuclear run-on assays indicate that suppression of lysyl oxidase expression in transformed subclones of CREF cells correlates with a reduction in transcription of the lysyl oxidase gene. Taken together, the current studies support a transcriptional switching model in which lysyl oxidase expression correlates directly with suppression of the Ka-ms-induced transformation phenotype and escape from oncogenic suppression correlates with a transcriptional silencing of the lysyl oxidase gene and decreased lysyl oxidase mRNA and protein.
Similar articles
- PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.
Su Z, Shi Y, Friedman R, Qiao L, McKinstry R, Hinman D, Dent P, Fisher PB. Su Z, et al. Nucleic Acids Res. 2001 Apr 15;29(8):1661-71. doi: 10.1093/nar/29.8.1661. Nucleic Acids Res. 2001. PMID: 11292838 Free PMC article. - Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).
Boylan JF, Jackson J, Steiner MR, Shih TY, Duigou GJ, Roszman T, Fisher PB, Zimmer SG. Boylan JF, et al. Anticancer Res. 1990 May-Jun;10(3):717-24. Anticancer Res. 1990. PMID: 2195986 Review. - Plasticity of CD44s expression during progression and metastasis of fibrosarcoma in an animal model system.
Culp LA, Kogerman P. Culp LA, et al. Front Biosci. 1998 Jul 1;3:d672-83. doi: 10.2741/a312. Front Biosci. 1998. PMID: 9634540 Review.
Cited by
- Characterizing a human lysyl oxidase chromosomal domain.
Martins RP, Krawetz SA. Martins RP, et al. Mol Biotechnol. 2000 Jul;15(3):225-35. doi: 10.1385/MB:15:3:225. Mol Biotechnol. 2000. PMID: 10986698 Review. - The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice.
Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, Goldstein NI, Fisher PB. Su ZZ, et al. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14400-5. doi: 10.1073/pnas.95.24.14400. Proc Natl Acad Sci U S A. 1998. PMID: 9826712 Free PMC article. - A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P, Fisher PB. Su Z, et al. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10332-7. doi: 10.1073/pnas.171315198. Proc Natl Acad Sci U S A. 2001. PMID: 11526239 Free PMC article. - Lysyl Oxidase and the Tumor Microenvironment.
Wang TH, Hsia SM, Shieh TM. Wang TH, et al. Int J Mol Sci. 2016 Dec 29;18(1):62. doi: 10.3390/ijms18010062. Int J Mol Sci. 2016. PMID: 28036074 Free PMC article. Review. - PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.
Su ZZ, Goldstein NI, Jiang H, Wang MN, Duigou GJ, Young CS, Fisher PB. Su ZZ, et al. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15115-20. doi: 10.1073/pnas.96.26.15115. Proc Natl Acad Sci U S A. 1999. PMID: 10611347 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials